Literature DB >> 27646959

Tolerogenic dendritic cells.

Maisa C Takenaka1, Francisco J Quintana2,3.   

Abstract

Deficits in immunological tolerance against self-antigens and antigens provided by the diet and commensal microbiota can result in the development of inflammatory and autoimmune disorders. Dendritic cells (DCs) are pivotal regulators of the immune response, specialized in antigen presentation to drive T cell priming and differentiation. DCs also have a tolerogenic function, participating in the enforcement of central and peripheral tolerance and the resolution of ongoing immune responses. Thus, DCs control effector and regulatory mechanisms relevant to the pathology of autoimmune disorders. In this review, we discuss recent findings regarding the control of the adaptive immune response by tolerogenic DCs. A thorough understanding of the mechanisms that control the tolerogenic DC phenotype will guide the development of novel strategies for the treatment of autoimmunity.

Entities:  

Keywords:  AhR; Autoimmunity; Dendritic cell; Nanoparticles; Tolerance

Mesh:

Substances:

Year:  2016        PMID: 27646959      PMCID: PMC5296314          DOI: 10.1007/s00281-016-0587-8

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  97 in total

1.  IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.

Authors:  Ivan D Mascanfroni; Ada Yeste; Silvio M Vieira; Evan J Burns; Bonny Patel; Ido Sloma; Yan Wu; Lior Mayo; Rotem Ben-Hamo; Sol Efroni; Vijay K Kuchroo; Simon C Robson; Francisco J Quintana
Journal:  Nat Immunol       Date:  2013-09-01       Impact factor: 25.606

2.  Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.

Authors:  Ada Yeste; Meghan Nadeau; Evan J Burns; Howard L Weiner; Francisco J Quintana
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-27       Impact factor: 11.205

3.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 4.  Plasmacytoid dendritic cells: recent progress and open questions.

Authors:  Boris Reizis; Anna Bunin; Hiyaa S Ghosh; Kanako L Lewis; Vanja Sisirak
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

5.  Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma.

Authors:  A H Enk; H Jonuleit; J Saloga; J Knop
Journal:  Int J Cancer       Date:  1997-11-04       Impact factor: 7.396

6.  Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells.

Authors:  Nir Yogev; Friederike Frommer; Dominika Lukas; Kordula Kautz-Neu; Khalad Karram; Daniele Ielo; Esther von Stebut; Hans-Christian Probst; Maries van den Broek; Dieter Riethmacher; Tal Birnberg; Thomas Blank; Boris Reizis; Thomas Korn; Heinz Wiendl; Steffen Jung; Marco Prinz; Florian C Kurschus; Ari Waisman
Journal:  Immunity       Date:  2012-08-16       Impact factor: 31.745

Review 7.  Tryptophan and the immune response.

Authors:  John R Moffett; Ma Aryan Namboodiri
Journal:  Immunol Cell Biol       Date:  2003-08       Impact factor: 5.126

8.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

9.  Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.

Authors:  Daniel Mucida; Yunji Park; Gisen Kim; Olga Turovskaya; Iain Scott; Mitchell Kronenberg; Hilde Cheroutre
Journal:  Science       Date:  2007-06-14       Impact factor: 47.728

10.  In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling.

Authors:  Henry Yim Wu; Francisco J Quintana; Andre Pires da Cunha; Benjamin T Dake; Thomas Koeglsperger; Sarah C Starossom; Howard L Weiner
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

View more
  51 in total

1.  Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity.

Authors:  Julio C Valencia; Nkolika Egbukichi; Rebecca A Erwin-Cohen
Journal:  J Interferon Cytokine Res       Date:  2018-12-18       Impact factor: 2.607

2.  Antigen-Presenting Cells: Potential of Proven und New Players in Immune Therapies.

Authors:  Britta Eiz-Vesper; Helga Maria Schmetzer
Journal:  Transfus Med Hemother       Date:  2020-11-10       Impact factor: 3.747

Review 3.  Natural and Induced Tolerogenic Dendritic Cells.

Authors:  Courtney A Iberg; Daniel Hawiger
Journal:  J Immunol       Date:  2020-02-15       Impact factor: 5.422

Review 4.  Role of AHR in the control of GBM-associated myeloid cells.

Authors:  Galina Gabriely; Francisco J Quintana
Journal:  Semin Cancer Biol       Date:  2019-05-23       Impact factor: 15.707

5.  IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.

Authors:  Satoshi Yoshimura; Rodolfo Thome; Shingo Konno; Elisabeth R Mari; Javad Rasouli; Daniel Hwang; Alexandra Boehm; Yanhua Li; Guang-Xian Zhang; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2019-12-18       Impact factor: 5.422

6.  Tolerogenic nanoparticles suppress central nervous system inflammation.

Authors:  Jessica E Kenison; Aditi Jhaveri; Zhaorong Li; Nikita Khadse; Emily Tjon; Sara Tezza; Dominika Nowakowska; Agustin Plasencia; Vincent P Stanton; David H Sherr; Francisco J Quintana
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-25       Impact factor: 11.205

Review 7.  Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells.

Authors:  Jessica Bourque; Daniel Hawiger
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 8.  Tolerance in the Age of Immunotherapy.

Authors:  Jeffrey A Bluestone; Mark Anderson
Journal:  N Engl J Med       Date:  2020-09-17       Impact factor: 91.245

Review 9.  The Gut-CNS Axis in Multiple Sclerosis.

Authors:  Atsushi Kadowaki; Francisco J Quintana
Journal:  Trends Neurosci       Date:  2020-07-07       Impact factor: 13.837

Review 10.  Regulation of the Immune Response by the Aryl Hydrocarbon Receptor.

Authors:  Cristina Gutiérrez-Vázquez; Francisco J Quintana
Journal:  Immunity       Date:  2018-01-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.